RACE
to Karolinska Institutet

Karolinska Institutet

Karolinska Institutet is a large and internationally recognized research centre and Sweden's major medical university. Karolinska Institutet accounts for 40 percent of all medical research at universities throughout Sweden. Its investigators collaborate internationally and nationally with other universities, major hospitals, and health related industry. Karolinska Institutet holds 28 departments that span over a broad field of research, from fundamental research in molecular biology to public health research.

The Department of Medical Epidemiology and Biostatistics (MEB) is one of the largest units of epidemiological research in Europe. The department has extensive experience from population-based epidemiological research using various designs. In these studies, information has been collected by means of mail questionnaires, telephone interviews, face-to-face interviews, record linkages, and abstraction of hospital record data or combinations of these different approaches.

Project staff

Professor Per Hall, coordinator, is Professor of Radiation Epidemiology. He is an internationally recognized epidemiologist and has been a consultant to the United Nations Scientific Committee on the Effects of Atomic Radiation, Vienna, and the International Agency for Research on Cancer, Lyon. His background is that of a medical oncologist at the Department of Oncology/Radiumhemmet, the Karolinska University Hospital for 15 years. The last 10 years were focused on breast cancer. The past 6 years have been devoted full time to epidemiological research. He is the Swedish PI on an awarded R01 contract that aims to evaluate the risk of lung cancer in women with breast cancer. He is Swedish PI in a NIH MAO/RFP study aiming at identifying individuals with a genetic susceptibility to radiation induced gastro-intestinal cancer.

Dr. Anna Bennet gained her doctorate three years ago and is working as an Epidemiologist at Karolinska Institutet. She is an expert on cardiovascular epidemiology and has published about 20 scientific papers on different novel, emerging risk factors for cardiovascular diseases, with particular emphasis on genetic and molecular markers for myocardial infarction. She also has a great interest in the biology of atherosclerosis and co-morbid disorders.

Dr. Giovanna Gagliardi is a radiation physicist at the Karolinska Hospital.  She is an expert on the early and late complications of radiation treatment and has published several papers on the adverse effects of external radiotherapy for breast cancer.  She has constructed algorithms for the calculation of dose-volume-histogram for different organs. 

Ann Almqvist, Senior Project Administration Manager, has long and thorough experience of project administration (two projects funded by the European Commission, three by NIH, two by US Army, several by the Swedish Cancer Society, and other funding agencies). She has experience in financial matters (budget calculations, preparing cost statements and invoices, etc.).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Producerad av Mediabyrån